POEMS Syndrome—Clinical Picture and Management. Current Knowledge

Artur Jurczyszyn; Magdalena Olszewska-Szopa; David Vesole

doi:10.1016/j.clml.2023.04.008

POEMS Syndrome—Clinical Picture and Management. Current Knowledge

Artur Jurczyszyn
, Magdalena Olszewska-Szopa
, David Vesole

School of Medicine

Hackensack Meridian School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

POEMS syndrome is a rare form of plasma cell dyscrasia. Difficulties arise already at the stage of making the diagnosis (complex and heterogeneous clinical picture) and continue during the course of treatment (lack of guidelines for therapy, data coming mainly from reports and short series of patients). In this article we review the current state of knowledge on POEMS syndrome diagnostics, clinical characteristics, prognosis, reported treatment outcomes and the emergence of the new therapeutic strategies.

Original language	English
Pages (from-to)	575-582
Number of pages	8
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	23
Issue number	8
DOIs	https://doi.org/10.1016/j.clml.2023.04.008
State	Published - Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Keywords

Clinical picture
POEMS syndrome
Plasma cell dyscrasia
Therapy

Access to Document

10.1016/j.clml.2023.04.008

Cite this

@article{82f3b3d4c9534473a5da3ea0149fbcb6,

title = "POEMS Syndrome{\textemdash}Clinical Picture and Management. Current Knowledge",

abstract = "POEMS syndrome is a rare form of plasma cell dyscrasia. Difficulties arise already at the stage of making the diagnosis (complex and heterogeneous clinical picture) and continue during the course of treatment (lack of guidelines for therapy, data coming mainly from reports and short series of patients). In this article we review the current state of knowledge on POEMS syndrome diagnostics, clinical characteristics, prognosis, reported treatment outcomes and the emergence of the new therapeutic strategies.",

keywords = "Clinical picture, POEMS syndrome, Plasma cell dyscrasia, Therapy",

author = "Artur Jurczyszyn and Magdalena Olszewska-Szopa and David Vesole",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2023",

month = aug,

doi = "10.1016/j.clml.2023.04.008",

language = "English",

volume = "23",

pages = "575--582",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier Inc.",

number = "8",

}

TY - JOUR

T1 - POEMS Syndrome—Clinical Picture and Management. Current Knowledge

AU - Jurczyszyn, Artur

AU - Olszewska-Szopa, Magdalena

AU - Vesole, David

PY - 2023/8

Y1 - 2023/8

N2 - POEMS syndrome is a rare form of plasma cell dyscrasia. Difficulties arise already at the stage of making the diagnosis (complex and heterogeneous clinical picture) and continue during the course of treatment (lack of guidelines for therapy, data coming mainly from reports and short series of patients). In this article we review the current state of knowledge on POEMS syndrome diagnostics, clinical characteristics, prognosis, reported treatment outcomes and the emergence of the new therapeutic strategies.

AB - POEMS syndrome is a rare form of plasma cell dyscrasia. Difficulties arise already at the stage of making the diagnosis (complex and heterogeneous clinical picture) and continue during the course of treatment (lack of guidelines for therapy, data coming mainly from reports and short series of patients). In this article we review the current state of knowledge on POEMS syndrome diagnostics, clinical characteristics, prognosis, reported treatment outcomes and the emergence of the new therapeutic strategies.

KW - Clinical picture

KW - POEMS syndrome

KW - Plasma cell dyscrasia

KW - Therapy

UR - https://www.scopus.com/pages/publications/85160102192

U2 - 10.1016/j.clml.2023.04.008

DO - 10.1016/j.clml.2023.04.008

M3 - Review article

C2 - 37210272

SN - 2152-2650

VL - 23

SP - 575

EP - 582

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 8

ER -

POEMS Syndrome—Clinical Picture and Management. Current Knowledge

Abstract

UN SDGs

ASJC Scopus subject areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this